 Allergan Inc raised doubts about Valeant Pharmaceuticals International Incs commitment to improving its transparency as it reiterated its opposition to a  billion hostile takeover bid from Valeant and activist investor William Ackman In an investor presentation Monday Allergan asserted Valeants disclosures likely will confirm the Botox makers concerns about its business model Valeant
  